Clinical Trials Directory

Trials / Completed

CompletedNCT02028169

To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)

To Observe the Impacts of Anti-TNF's Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis

Status
Completed
Phase
Study type
Observational
Enrollment
120 (actual)
Sponsor
AbbVie · Industry
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This post marketing observational study is designed to provide the initial data on work impairment of PsA patients in Turkey, as well as changes in work impairment, life quality and clinical response during treatment with anti-TNF agents.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2016-04-01
Completion
2016-04-01
First posted
2014-01-07
Last updated
2017-04-27
Results posted
2017-04-27

Source: ClinicalTrials.gov record NCT02028169. Inclusion in this directory is not an endorsement.

To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Prod (NCT02028169) · Clinical Trials Directory